Skin, hair and healthy aging
What human research has studied for skin conditions, hair, nails and healthy-aging measures, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.
How strong the evidence is
Where skin, hair and healthy aging sits on the supplement body map; colored by its strongest grade here.
Findings by ingredient
| Ingredient | Grade | What was studied and found |
|---|---|---|
| Astaxanthin | B | Skin aging (moisture, elasticity, wrinkles). 2021 meta-analysis of 9 RCTs of oral astaxanthin: skin moisture (SMD 0.53) and elasticity (SMD 0.77) improved versus placebo; wrinkle depth did not change significantly. sources |
| Glutathione | B | Skin lightening (melanin index) in healthy people. A 2025 systematic review describes five RCTs and one open-arm study in which oral glutathione (250-500 mg/day) reduced melanin index versus placebo; it judged topical and oral effects moderate and not sustained. sources |
| Hyaluronic acid (oral) | B | Skin hydration in healthy adults. A meta-analysis of 4 RCTs (196 participants, 4–12 weeks) found improved skin hydration versus placebo (SMD +0.40); trial designs were poorly reported and one trial had high risk of other bias. sources |
| Argan oil | C | Skin elasticity in postmenopausal women. In 60 postmenopausal women, 60 days of dietary argan oil (versus olive oil) and topical argan oil both increased instrument-measured skin elasticity. sources |
| Biotin | C | Brittle nails. Small uncontrolled studies of 2.5 mg/day for about 5.5–15 months (22 to 45 patients each) reported firmer nails or improvement in 63%–91%; ODS calls the support few case reports and small studies. sources |
| Biotin | C | Hair and skin. Evidence consists of case reports in children (3–5 mg/day for uncombable hair syndrome) and infants (100 mcg to 10 mg/day for rash and alopecia); ODS states future studies are needed. sources |
| Calendula | C | Acute radiation dermatitis during radiotherapy (topical, pooled trials). A 2023 meta-analysis of RCTs of natural agents applied during radiotherapy found calendula did not significantly lower the incidence of grade 2+ radiation dermatitis; the authors called the evidence for natural agents inconsistent. sources |
| Calendula | C | Radiation dermatitis in breast cancer radiotherapy versus trolamine (topical). A phase III RCT in 254 breast cancer patients found grade 2 or higher acute dermatitis was less frequent with calendula ointment than trolamine (41% vs 63%), with less radiation-induced pain. sources |
| Calendula | C | Wound healing (topical). A 2019 systematic review of calendula extract alone (7 clinical trials, 7 animal studies) found some evidence for acute wounds and mixed results for venous and diabetic ulcers and burns; larger trials are needed. sources |
| Calendula | C | Diaper dermatitis in infants (topical). In a 100-infant RCT, bentonite cream worked faster and more completely than calendula cream (86% vs 52% of infants with lesions completely improved within three days). sources |
| Collagen peptides | C | Skin hydration, elasticity and wrinkles. A 2025 meta-analysis of 23 RCTs (1,474 participants) found overall improvements, but trials without pharmaceutical-company funding and high-quality trials showed no significant effect. sources |
| Dunaliella | C | Mild chronic plaque psoriasis. In a 12-week double-blind RCT in 34 adults, D. bardawil capsules reduced PASI scores more than placebo at 6 weeks (61.3% vs 34%); quality-of-life scores did not differ. sources |
| Haritaki | C | Facial sebum, redness and wrinkles in healthy women. An 8-week placebo-controlled RCT of 250 mg capsules twice daily reported less forehead sebum in women with high baseline sebum, less cheek redness and lower facial wrinkle severity than placebo. sources |
| Honeybush | C | Facial wrinkles and skin aging (oral extract). In one 12-week randomized, placebo-controlled trial in 120 Korean adults, 400 or 800 mg/day of fermented C. intermedia extract improved wrinkle grade, elasticity and hydration versus placebo. sources |
| Honeybush | C | Skin smoothness and hydration (topical cream). In a 2-week forearm study, 2% C. maculata or C. genistoides creams improved skin smoothness but did not improve hydration compared with placebo; the formulations were unstable over 3 months. sources |
| Hyaluronic acid (oral) | C | Skin photoaging and elasticity. A 2025 meta-analysis identified 4 studies (178 participants); pooling 2 (100 participants) found no significant difference from placebo in overall skin elasticity, with high heterogeneity. sources |
| Manuka honey | C | Wound healing (applied to the skin). MSK: small clinical studies suggest benefit, but randomized trials did not find manuka honey more effective than standard treatments for venous leg ulcers, eyelid surgical wounds or catheter-associated infections. sources |
| MSM (methylsulfonylmethane) | C | Facial wrinkles and skin texture. In a 16-week pilot of 20 participants, 3 g/day MSM reduced facial wrinkles and skin roughness versus placebo; a second part compared 1 g and 3 g/day without a placebo group. sources |
| Propolis | C | Warts and fungal foot infections. MSK states that data in humans are limited; small trials suggest benefit for warts and fungal foot infections. sources |
| Pumpkin seed | C | Male pattern hair loss. In a 24-week double-blind RCT in 76 men, 400 mg/day of a pumpkin seed oil product increased hair counts by 40% versus 10% with placebo. sources |
| Purslane | C | Chronic hand eczema (oral syrup). A 4-week RCT in 70 adults found purslane syrup plus topical Vaseline lowered fissure, itching and dryness scores versus placebo syrup plus Vaseline. sources |
| Rose hip | C | Facial wrinkles and skin moisture. In one 8-week randomized study of 34 adults, rose hip powder and the comparator astaxanthin both improved crow's-feet wrinkles, moisture and elasticity; there was no placebo group. sources |
| Rosemary | C | Androgenetic alopecia (pattern hair loss). A 6-month randomized trial in 100 patients found similar hair-count gains with topical rosemary oil and 2% minoxidil; there was no placebo group. sources |
| Sangre de grado | C | Insect bites and minor skin reactions (topical balm). Pest-control workers preferred a sangre de grado balm over placebo for itching, pain and swelling from insect bites, cuts and plant reactions; the published abstract gives few trial details. sources |
| Saw palmetto | C | Male-pattern hair loss. A few small oral or scalp-applied studies; NCCIH states the evidence is too limited for conclusions. sources |
| Spearmint | C | Androgen levels and hirsutism in women with PCOS. In a 30-day RCT of 42 women, spearmint tea twice daily lowered free and total testosterone and self-rated hirsutism versus placebo tea, but not the clinician-rated hirsutism score. sources |
| Spearmint | C | Androgen levels in women with hirsutism (uncontrolled study). In a 5-day study without a control group (21 women), spearmint tea twice daily lowered free testosterone and raised LH, FSH and estradiol; total testosterone did not change. sources |
| Resveratrol | D | Lifespan and aging. Marketing as an anti-aging supplement rests on longer life span in yeast cells; this effect has not been demonstrated in humans. sources |
| GLA oils (borage and blackcurrant seed oil) | X | Atopic eczema. A 2013 Cochrane review (27 RCTs, 1,596 participants; 8 of borage oil) found borage oil did not improve global eczema symptoms versus placebo and concluded oral borage oil lacks effect on eczema. sources |
| GLA oils (borage and blackcurrant seed oil) | X | Atopic eczema in children and adults (single large trial). A 12-week RCT (151 patients, 140 evaluable; adults 920 mg GLA/day) found no benefit of borage oil over placebo on eczema sign scores (difference 1.4 points in favor of placebo, P = 0.45). sources |
| Lacticaseibacillus rhamnosus GG (LGG) | X | Eczema risk in young children. A meta-analysis of five RCTs (889 participants) found LGG, given to children or to mothers in pregnancy or breastfeeding, did not reduce eczema risk up to age 4. sources |
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.